A Prospective, Non-interventional Multi-center Observational Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis in Routine Practice
Phase of Trial: Phase IV
Latest Information Update: 11 Jul 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Roche
- 01 Jul 2016 Planned End Date changed from 1 Jun 2018 to 1 Jun 2017.
- 01 Jul 2016 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2017.
- 01 Mar 2016 Planned End Date changed from 1 Dec 2016 to 1 Jun 2018 as reported by ClinicalTrials.gov.